Projects funded by the NCN
Development of novel anti-cancer immunotherapy against mesothelioma comprising of oncolytic adenovirus vectors armed with ICOS and CD40 ligands in combination with checkpoint inhibitors anti-PD-1 and anti-CTLA-4
2022/47/D/NZ7/03212
Keywords:
immuno-oncology oncolytic adenoviruses CD40 ligand ICOS ligand checkpoint inhibitors anti-PD-1 anti-CTLA-4 preclinical studies
Descriptors:
- NZ6_5: Virology
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Narodowy Instytut Zdrowia Publicznego PZH - Państwowy Instytut Badawczy
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: SONATA 18 - announced on 2022-07-15
Amount awarded: 1 930 370 PLN
Project start date (Y-m-d): 2023-07-06
Project end date (Y-m-d): 2026-07-05
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.